StockData
IN8bio, Inc. logo

IN8bio, Inc. (INAB) stock

INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.82+0.00 (+0.49%)

Close on Nov 17, 2026Market cap $8.08MP/E –Yield –

IN8bio total assets

Total assets on the balance sheet at the end of each period.

IN8bio's total assets was $21.75M at Jun 30, 2026. For fiscal 2025 it was $32.28M, up 54.1% from the year before. The highest annual figure on record is $42.22M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$32.28M+54.1%
FY2024Dec 31, 2024$20.94M-37.9%
FY2023Dec 31, 2023$33.71M+2.0%
FY2022Dec 31, 2022$33.04M-21.8%
FY2021Dec 31, 2021$42.22M+101.9%
FY2020Dec 31, 2020$20.91M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$21.75M+12.3%
Q1 FY2026Mar 31, 2026$26.27M+32.2%
Q4 FY2025Dec 31, 2025$32.28M+54.1%
Q3 FY2025Sep 30, 2025$16.77M+5.0%
Q2 FY2025Jun 30, 2025$19.37M-13.9%
Q1 FY2025Mar 31, 2025$19.87M-41.1%
Q4 FY2024Dec 31, 2024$20.94M-20.1%
Q3 FY2024Sep 30, 2024$15.97M-46.3%
Q2 FY2024Jun 30, 2024$22.50M-8.8%
Q4 FY2023Dec 31, 2023$33.71M+2.0%
Q3 FY2023Sep 30, 2023$26.21M-31.7%
Q2 FY2023Jun 30, 2023$29.72M-4.1%
Q1 FY2023Mar 31, 2023$24.68M-32.5%
Q4 FY2022Dec 31, 2022$33.04M-21.8%
Q3 FY2022Sep 30, 2022$38.38M-18.6%
Q2 FY2022Jun 30, 2022$30.99M+76.4%
Q1 FY2022Mar 31, 2022$36.54M+74.7%
Q4 FY2021Dec 31, 2021$42.22M–
Q3 FY2021Sep 30, 2021$47.13M–
Q2 FY2021Jun 30, 2021$17.56M–
Q4 FY2020Dec 31, 2020$20.91M–

More IN8bio figures

See a number that looks wrong?